Michael Gallagher, MD, has been named medical director and chairman of the medical advisory board of eNotes Systems (Los Angeles). Gallagher has served as vice chairman of the Cardiothoracic Surgical Section at Memorial Hospital Southwest and as a clinical assistant professor in the Department of Surgery at the University of Texas Medical School. Gallagher will assist in the design and coordination of the clinical aspects of the company's telemedicine products and services.

James Buck has been named vice president, marketing and business development for InnerPulse (Research Triangle Park, North Carolina). Buck most recently was vice president, marketing and business development for Closure Medical. Before joining Closure, Buck spent 11 years at St. Jude Medical. InnerPulse is an early-stage company developing the Percutaneous Implantable Cardioverter Defibrillator (PICD).

Patricia Daniel has been named vice president of the Medical Review Unit of Lumetra (San Francisco), replacing Terry Ramirez, who retired in June. Previously, Daniel held positions of similar responsibility at Health Net of California.

Raoul Bonan, MD, an interventional cardiologist, has been named a clinical consultant for MIV Therapeutics (Atlanta) to oversee the next phases of MIVT's research and human clinical studies. Bonan during his career has helped develop and obtain FDA approval for several interventional cardiac devices, including one of the first PTCA balloons, MIVT said. MIVT develops next-generation cardiovascular stent technology based on its proprietary hydroxyapatite (HAp) technology.

Fiona Sander has been appointed to director of research and clinical affairs for NovaShunt (Zurich, Switzerland/Saratoga, California), a developer of implantable automated fluid management technologies. Most recently, Sander was director of research at BaroSense. NovaShunt manufactures automated implantable pump systems to remove chronic fluid build-up in the body.

No Comments